- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05593718
Comparison of HFNO and FMV on Desaturations During Panendoscopy Under General Anesthesia
Comparison of High-flow Nasal Oxygen Therapy and Face Mask Ventilation on Desaturations During Panendoscopy Under General Anesthesia
Panendoscopy is a common procedure that requires deep and short anesthesia. The main challenge is the sharing of the airway between the anesthesia team and the surgical team. There are several methods to ensure oxygenation during this type of procedure: oro-tracheal intubation, jet ventilation, spontaneous ventilation anesthesia, apneic ventilation with intermittent face mask ventilation. There is no consensus regarding the best airway management technique for this procedure. Regardless of the method chosen to ensure oxygenation during this procedure, the risk of hypoxemia during desaturation episodes is significant.
However, the use of HFNO seems to show a prolongation of apnea time without desaturations (< 90% SpO2) and seems to allow the performance of panendocoscopies.
In the Besançon University Hospital, since 2017, all panendoscopies are performed with HFNO. Before 2017, panendoscopies were performed under face mask ventilation. The main of the study hypothesis is that HFNO brought a gain in terms of safety, especially on the desaturation rate compared to face mask ventilation.
The investigators will carry out a quasi-experimental study comparing two periods. The first period concerns the years 2015-2016. It aims to study patients who had panendoscopies performed under FMV. The second period covers the years 2018-2019. It aims to study patients who had panendoscopies performed under HFNO.
The year 2017 is considered as the washout period necessary to avoid the learning effect of the HFNO introduced during that year.
Study Overview
Status
Conditions
Detailed Description
Currently, there are several strategies to ensure oxygenation during this specific type of ENT management:
- Mechanical ventilation with oro-tracheal intubation (OTI)
- face mask ventilation (FMV)
- Jet ventilation
- HFNO Each of these methods has advantages and disadvantages, which explains why there are no clear recommendations to date on the preferred anesthesia and oxygenation technique. Regardless of the method chosen, the risks remain significant for the patient, particularly the risk of hypoxemia during a desaturation episode.
In 2017, HFNO was introduced for panendoscopies in the Besançon University Hospital. Before 2017, panendoscopies were mainly perfomed with intermittent face mask ventilation.
The objective of the study is to compare the FMV group (patients receiving panendoscopy and ventilated with FMV during 2015-2016) with the HFNO group (patients receiving panendoscopy and oxygenated with HFNO during 2018-2019) with respect to perprocedural hypoxemia (SpO2<90% for more than 1 minute).
Secondary objectives are to compare complications, use of oro-tracheal intubation, and procedure duration between the two oxygenation methods.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: David Ferreira, MD, PhD
- Phone Number: +33642841108
- Email: dferreira@chu-besancon.fr
Study Locations
-
-
Franche Comté
-
Besançon, Franche Comté, France, 25000
- CENTRE HOSPITALIER UNIVERSITAIRE de BESANCON
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Face Mask Ventilation (FMV) Group :patients who had panendoscopies performed under FMV during the years 2015-2016.
HFNO group :patients who had panendoscopies performed under HFNO during the years the years 2018-2019.
Description
Inclusion Criteria:
- major patients receiving panendoscopy
- patients ventilated by face mask during the first period,
- patients receiving oxygen by HFNO during the second period
Exclusion Criteria:
- Patients receiving ventilatory strategy other than those selected by time period.
- Patients receiving panendoscopies performed with a method of oxygenation other than those defined in their period.
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
|---|
|
FaceMask Ventilation (FMV)
During the period from January 1, 2015, to December 31, 2016, all panendoscopies performed with FMV, whether urgent or scheduled and regardless of indication, were included.
Panendoscopies performed with any other oxygenation method were excluded.
|
|
HFNO
During the period from January 1, 2018, to December 31, 2019, all panendoscopies performed with HFNO, urgent or scheduled and regardless of indication, were included.
Panendoscopies performed with any other oxygenation method were excluded.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of patients with oxygen desaturation
Time Frame: more than 1 minute during the intervention
|
Proportion of patients with oxygen desaturation (SpO2 < 90%) for more than 1 minute.
|
more than 1 minute during the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion of patients requiring repeat face mask ventilation
Time Frame: more than 1 minute during the intervention
|
Proportion of patients requiring repeat face mask ventilation (at least one reventilation outside the initial denitrogenation)
|
more than 1 minute during the intervention
|
|
Proportion of patients requiring oro-tracheal intubation
Time Frame: during the intervention (max 6hours)from induction of anaesthesia to discharge from the operating theatre
|
Proportion of patients intubated during panendoscopy
|
during the intervention (max 6hours)from induction of anaesthesia to discharge from the operating theatre
|
|
Duration of the procedure
Time Frame: during the intervention (max 6hours) from induction of anaesthesia to discharge from the operating theatre
|
Time (minutes) from induction of anaesthesia to discharge from the operating theatre
|
during the intervention (max 6hours) from induction of anaesthesia to discharge from the operating theatre
|
|
Incidence of mild intraoperative complications
Time Frame: more than 1 minute during the intervention
|
Complications are : mild bradycardia (between 45 and 30 beats per minute), hypotension defined by MAP (between 65 and 40mmHg), hypercapnia (betaween 60 and 80 mmHg)
|
more than 1 minute during the intervention
|
|
Incidence of major intraoperative complications
Time Frame: more than 1 minute during the intervention
|
Complications are : Tracheotomy, extreme bradycardia < 30 beats per minute, hemodynamic instability defined by MAP < 40mmHg, hypercapnia (more than 80 mmHg)
|
more than 1 minute during the intervention
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- ID052021HFNO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on ENT Tumor
-
Centre Hospitalier Universitaire de BesanconNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceNot yet recruiting
-
Gustave Roussy, Cancer Campus, Grand ParisCompleted
-
University Hospital, BonnMasimo Corp. (loan of medical devices); Villa Sana GmbH (loan of medical devices)Completed
-
Fayoum University HospitalNot yet recruiting
-
Nantes University HospitalCompletedGynecological Surgery | Plastic Surgery | ENT SurgeryFrance
-
Loma Linda UniversityCompletedComparison of Telemedicine Evaluation to Standard Evaluation Methods for Pre-Anesthesia ConsultationENT Patients Scheduled for SurgeryUnited States
-
Nationwide Children's HospitalCompletedPatients Undergoing ENT Surgery With Cuffed ETTUnited States
-
Region SkaneLund UniversityCompletedAdvanced ENT Surgery | Microbiological Flora in the Oropharynx and Lower AirwaysSweden
-
National Health Service, United KingdomCompletedENT DiseaseUnited Kingdom